Background Clonal hematopoiesis of indeterminate potential (CHIP)—the age-related clonal
expansion of blood stem cells with leukemia-associated mutations—is a novel …

Background: Clonal hematopoiesis (CH) of indeterminate potential (CHIP) is a risk factor for
cardiovascular disease. The relationship between CHIP and coronary microvascular …

Background Age-related clonal hematopoiesis of indeterminate potential (CHIP), defined as
clonally expanded leukemogenic sequence variations (particularly in DNMT3A, TET2 …

Background Presence of clonal hematopoiesis of indeterminate potential (CHIP) is
associated with a higher risk of atherosclerotic cardiovascular disease, cancer, and …

A novel, common, and potent cardiovascular risk factor has recently emerged: clonal
hematopoiesis of indeterminate potential (CHIP). CHIP arises from somatic mutations in …

Importance Despite current standards of cardiovascular care, a considerable residual
burden of risk remains in both primary and secondary prevention. Clonal hematopoiesis of …

Background Clonal hematopoiesis of indeterminate potential (CHIP) is a novel
cardiovascular disease (CVD) risk factor in individuals without acute myeloid leukemia …

Background Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the
presence of an expanded somatic blood-cell clone in persons without other hematologic …

Importance Clonal hematopoiesis of indeterminate potential (CHIP), the expansion of
somatic leukemogenic variations in hematopoietic stem cells, has been associated with …

Clonal hematopoiesis of indeterminate potential (CHIP) is the presence of a clonally
expanded hematopoietic stem cell caused by a leukemogenic mutation in individuals …